Filter by:

pbac.pbs.gov.au

/var/www/disclogs/web/web/showDomain.php (line 14)
  • reset($query->fetchAll(PDO::FETCH_ASSOC))
    9
    array
    • domain_name
      pbac.pbs.gov.au
      15
      string
    • second_level_domain_name
      pbs.gov.au
      10
      string
    • whois
      null
      null
    • dns
      {"A": ["111.125.165.170"]}
      stringjsonobject
    • ip_whois
      {"asn": "132071", "nir": null, "raw": null, "query": "111.125.165.170", "network": {"raw": null, "cidr": "111.125.160.0/20", "name": "INTERVOLVE-AU", "type": "ALLOCATED PORTABLE", "links": ["http://rdap.apnic.net/ip/111.125.160.0/20"], "events": [{"actor": null, "action": "last changed", "timestamp": "2017-08-30T07:20:30Z"}], "handle": "111.125.160.0 - 111.125.175.255", "status": null, "country": "AU", "notices": [{"links": null, "title": "Source", "description": "Objects returned came from source\nAPNIC"}, {"links": ["http://www.apnic.net/db/dbcopyright.html"], "title": "Terms and Conditions", "description": "This is the APNIC WHOIS Database query service. The objects are in RDAP format."}], "remarks": [{"links": null, "title": "description", "description": "Intervolve\nAustralian Colocation, Dedicated Servers, Web Hosting\nAdelaide, Brisbane, Melbourne, Perth & Sydney\nContact us today on 1300 664 574!\nwww.intervolve.com.au"}, {"links": null, "title": "remarks", "description": "--------------------------------------------------------\nTo report network abuse, please contact mnt-irt\nFor troubleshooting, please contact tech-c and admin-c\nReport invalid contact via www.apnic.net/invalidcontact\n--------------------------------------------------------"}], "ip_version": "v4", "end_address": "111.125.175.255", "parent_handle": null, "start_address": "111.125.160.0"}, "objects": {"RM390-AP": {"raw": null, "links": ["http://rdap.apnic.net/entity/RM390-AP"], "roles": ["administrative"], "events": null, "handle": "RM390-AP", "status": null, "contact": {"kind": "individual", "name": "Richard Macko", "role": null, "email": [{"type": null, "value": "support@intervolve.com.au"}], "phone": [{"type": "voice", "value": "+61-8-8260-4237"}, {"type": "fax", "value": "+61-8-8260-4312"}], "title": null, "address": [{"type": null, "value": "14 Williams Circuit\\nPooraka SA 5095"}]}, "notices": null, "remarks": null, "entities": null, "events_actor": null}, "CM1860-AP": {"raw": null, "links": ["http://rdap.apnic.net/entity/CM1860-AP"], "roles": ["technical"], "events": null, "handle": "CM1860-AP", "status": null, "contact": {"kind": "individual", "name": "Chris Macko", "role": null, "email": [{"type": null, "value": "cmacko@intervolve.com.au"}], "phone": [{"type": "voice", "value": "+61-8-8260-4237"}, {"type": "fax", "value": "+61-8-8260-4312"}], "title": null, "address": [{"type": null, "value": "14 Williams Circuit\\nPooraka SA 5095"}]}, "notices": null, "remarks": null, "entities": null, "events_actor": null}, "IRT-INTERVOLVE-AU": {"raw": null, "links": ["http://rdap.apnic.net/entity/IRT-INTERVOLVE-AU"], "roles": ["abuse"], "events": null, "handle": "IRT-INTERVOLVE-AU", "status": null, "contact": {"kind": "group", "name": "IRT-INTERVOLVE-AU", "role": null, "email": [{"type": null, "value": "support@intervolve.com.au"}, {"type": null, "value": "support@intervolve.com.au"}], "phone": null, "title": null, "address": [{"type": null, "value": "14 Williams Circuit\\nPooraka SA 5095"}]}, "notices": null, "remarks": null, "entities": null, "events_actor": null}}, "asn_cidr": "111.125.164.0/23", "asn_date": "2009-07-06", "entities": ["IRT-INTERVOLVE-AU", "CM1860-AP", "RM390-AP"], "asn_registry": "apnic", "asn_description": "INTERVOLVE-SYDNEY-AS-AP Interhost Pacific Pty Ltd t/a Intervolve, AU", "asn_country_code": "AU"}
      stringjsonobject
      • asn
        132071
        6
        string
      • nir
        null
        null
      • raw
        null
        null
      • query
        111.125.165.170
        15
        string
      • asn_cidr
        111.125.164.0/23
        16
        string
      • asn_date
        2009-07-06
        -9y 5m
        stringdatetime
      • asn_registry
        apnic
        5
        string
      • asn_description
        INTERVOLVE-SYDNEY-AS-AP Interhost Pacific Pty Ltd t/a Intervolve, AU
        68
        string
      • asn_country_code
        AU
        2
        string
    • active
      true
      boolean
    • data_created_at
      2018-03-30 04:13:09.790107+00
      -8m 5w
      stringdatetime
    • data_updated_at
      2018-04-02 03:43:17.071264+00
      -8m 4w
      stringdatetime
    • https
      {"ocsp_response": {"version": "1", "responses": [{"certID": {"serialNumber": "205087C3499A2802402A5CF84E145F32", "hashAlgorithm": "sha1", "issuerKeyHash": "90AF6A3A945A0BD890EA125673DF43B43A28DAE7", "issuerNameHash": "7AE13EE8A0C42A2CB428CBE7A605461940E2A1E9"}, "certStatus": "good", "nextUpdate": "Apr 7 01:38:07 2018 GMT", "thisUpdate": "Mar 31 01:38:07 2018 GMT"}], "producedAt": "Mar 31 01:38:07 2018 GMT", "responderID": "90AF6A3A945A0BD890EA125673DF43B43A28DAE7", "responseType": "Basic OCSP Response", "responseStatus": "successful"}, "certificate_chain": [{"issuer": {"commonName": "COMODO RSA Domain Validation Secure Server CA", "countryName": "GB", "localityName": "Salford", "organizationName": "COMODO CA Limited", "stateOrProvinceName": "Greater Manchester"}, "subject": {"commonName": "*.pbs.gov.au", "organizationalUnitName": "PositiveSSL Wildcard"}, "keyUsage": "<KeyUsage(digital_signature=True, content_commitment=False, key_encipherment=True, data_encipherment=False, key_agreement=False, key_cert_sign=False, crl_sign=False, encipher_only=None, decipher_only=None)>", "subjectAltName": ["*.pbs.gov.au", "pbs.gov.au"], "not_valid_after": "2020-01-13T23:59:59", "basicConstraints": "<BasicConstraints(ca=False, path_length=None)>", "extendedKeyUsage": "<ExtendedKeyUsage([<ObjectIdentifier(oid=1.3.6.1.5.5.7.3.1, name=serverAuth)>, <ObjectIdentifier(oid=1.3.6.1.5.5.7.3.2, name=clientAuth)>])>", "not_valid_before": "2017-01-06T00:00:00", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.2, name=caIssuers)>, access_location=<UniformResourceIdentifier(value='http://crt.comodoca.com/COMODORSADomainValidationSecureServerCA.crt')>)>, <AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://ocsp.comodoca.com')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=1.3.6.1.4.1.6449.1.2.2.7, name=Unknown OID)>, policy_qualifiers=['https://secure.comodo.com/CPS'])>, <PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.23.140.1.2.1, name=Unknown OID)>, policy_qualifiers=None)>])>", "subjectKeyIdentifier": "<SubjectKeyIdentifier(digest=b'}\\x952\\xa0e(\\r\\xd6\\xb9\\x893\\x8e\\x9b=\\xdd\\xbdn#G\\xea')>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://crl.comodoca.com/COMODORSADomainValidationSecureServerCA.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'\\x90\\xafj:\\x94Z\\x0b\\xd8\\x90\\xea\\x12Vs\\xdfC\\xb4:(\\xda\\xe7', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha256"}, {"issuer": {"commonName": "COMODO RSA Certification Authority", "countryName": "GB", "localityName": "Salford", "organizationName": "COMODO CA Limited", "stateOrProvinceName": "Greater Manchester"}, "subject": {"commonName": "COMODO RSA Domain Validation Secure Server CA", "countryName": "GB", "localityName": "Salford", "organizationName": "COMODO CA Limited", "stateOrProvinceName": "Greater Manchester"}, "keyUsage": "<KeyUsage(digital_signature=True, content_commitment=False, key_encipherment=False, data_encipherment=False, key_agreement=False, key_cert_sign=True, crl_sign=True, encipher_only=None, decipher_only=None)>", "not_valid_after": "2029-02-11T23:59:59", "basicConstraints": "<BasicConstraints(ca=True, path_length=0)>", "extendedKeyUsage": "<ExtendedKeyUsage([<ObjectIdentifier(oid=1.3.6.1.5.5.7.3.1, name=serverAuth)>, <ObjectIdentifier(oid=1.3.6.1.5.5.7.3.2, name=clientAuth)>])>", "not_valid_before": "2014-02-12T00:00:00", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.2, name=caIssuers)>, access_location=<UniformResourceIdentifier(value='http://crt.comodoca.com/COMODORSAAddTrustCA.crt')>)>, <AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://ocsp.comodoca.com')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.5.29.32.0, name=Unknown OID)>, policy_qualifiers=None)>, <PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.23.140.1.2.1, name=Unknown OID)>, policy_qualifiers=None)>])>", "subjectKeyIdentifier": "<SubjectKeyIdentifier(digest=b'\\x90\\xafj:\\x94Z\\x0b\\xd8\\x90\\xea\\x12Vs\\xdfC\\xb4:(\\xda\\xe7')>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://crl.comodoca.com/COMODORSACertificationAuthority.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'\\xbb\\xaf~\\x02=\\xfa\\xa6\\xf1<\\x84\\x8e\\xad\\xee8\\x98\\xec\\xd922\\xd4', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha384"}, {"issuer": {"commonName": "AddTrust External CA Root", "countryName": "SE", "organizationName": "AddTrust AB", "organizationalUnitName": "AddTrust External TTP Network"}, "subject": {"commonName": "COMODO RSA Certification Authority", "countryName": "GB", "localityName": "Salford", "organizationName": "COMODO CA Limited", "stateOrProvinceName": "Greater Manchester"}, "keyUsage": "<KeyUsage(digital_signature=True, content_commitment=False, key_encipherment=False, data_encipherment=False, key_agreement=False, key_cert_sign=True, crl_sign=True, encipher_only=None, decipher_only=None)>", "not_valid_after": "2020-05-30T10:48:38", "basicConstraints": "<BasicConstraints(ca=True, path_length=None)>", "not_valid_before": "2000-05-30T10:48:38", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://ocsp.usertrust.com')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.5.29.32.0, name=Unknown OID)>, policy_qualifiers=None)>])>", "subjectKeyIdentifier": "<SubjectKeyIdentifier(digest=b'\\xbb\\xaf~\\x02=\\xfa\\xa6\\xf1<\\x84\\x8e\\xad\\xee8\\x98\\xec\\xd922\\xd4')>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://crl.usertrust.com/AddTrustExternalCARoot.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'\\xad\\xbd\\x98z4\\xb4&\\xf7\\xfa\\xc4&T\\xef\\x03\\xbd\\xe0$\\xcbT\\x1a', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha384"}], "SSLV2 Cipher Suites": [], "SSLV3 Cipher Suites": [], "TLSV1 Cipher Suites": ["TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_DHE_RSA_WITH_AES_256_CBC_SHA", "TLS_DHE_RSA_WITH_CAMELLIA_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_CAMELLIA_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_DHE_RSA_WITH_AES_128_CBC_SHA", "TLS_DHE_RSA_WITH_CAMELLIA_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_CAMELLIA_128_CBC_SHA", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "ocsp_response_status": 0, "TLSV1_1 Cipher Suites": ["TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_DHE_RSA_WITH_AES_256_CBC_SHA", "TLS_DHE_RSA_WITH_CAMELLIA_256_CBC_SHA", "TLS_RSA_WITH_CAMELLIA_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_DHE_RSA_WITH_AES_128_CBC_SHA", "TLS_DHE_RSA_WITH_CAMELLIA_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_CAMELLIA_128_CBC_SHA", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "TLSV1_2 Cipher Suites": ["TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384", "TLS_RSA_WITH_AES_256_GCM_SHA384", "TLS_DHE_RSA_WITH_AES_256_GCM_SHA384", "TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA256", "TLS_DHE_RSA_WITH_CAMELLIA_256_CBC_SHA", "TLS_DHE_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_CAMELLIA_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384", "TLS_DHE_RSA_WITH_AES_256_CBC_SHA256", "TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256", "TLS_DHE_RSA_WITH_AES_128_GCM_SHA256", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA256", "TLS_RSA_WITH_AES_128_GCM_SHA256", "TLS_RSA_WITH_CAMELLIA_128_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA256", "TLS_DHE_RSA_WITH_AES_128_CBC_SHA", "TLS_DHE_RSA_WITH_AES_128_CBC_SHA256", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_DHE_RSA_WITH_CAMELLIA_128_CBC_SHA", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "TLSV1_3 Cipher Suites": [], "is_leaf_certificate_ev": false, "is_ocsp_response_trusted": true, "symantec_distrust_timeline": null, "tls_server_name_indication": "pbac.pbs.gov.au", "certificate_matches_hostname": true, "has_sha1_in_certificate_chain": false, "highest_ssl_version_supported": "TLSV1_2", "certificate_included_scts_count": 0, "has_anchor_in_certificate_chain": false, "openssl_cipher_string_supported": "ECDHE-RSA-AES128-GCM-SHA256", "is_certificate_chain_order_valid": true, "certificate_has_must_staple_extension": false}
      stringjsonobject
      • ocsp_response_status
        0
        integer
      • is_leaf_certificate_ev
        false
        boolean
      • is_ocsp_response_trusted
        true
        boolean
      • symantec_distrust_timeline
        null
        null
      • tls_server_name_indication
        pbac.pbs.gov.au
        15
        string
      • certificate_matches_hostname
        true
        boolean
      • has_sha1_in_certificate_chain
        false
        boolean
      • highest_ssl_version_supported
        TLSV1_2
        7
        string
      • certificate_included_scts_count
        0
        integer
      • has_anchor_in_certificate_chain
        false
        boolean
      • openssl_cipher_string_supported
        ECDHE-RSA-AES128-GCM-SHA256
        27
        string
      • is_certificate_chain_order_valid
        true
        boolean
      • certificate_has_must_staple_extension
        false
        boolean
titlepathsize_bytesword_countload_time
PBAC Guidelines | Website Home Page / 29190 581
PBAC Guidelines | Appendix 1 Expert opinion /appendixes/appendix-1-expert-opinion.html 59816 2222 0.615434132
PBAC Guidelines | Appendix 2 Literature search methods /appendixes/appendix-2-literature-search-methods.html 58226 1342 0.134392586
PBAC Guidelines | Appendix 3 Identify relevant trials /appendixes/appendix-3-identify-relevant-trials.html 68188 2318 0.759107972
PBAC Guidelines | Appendix 4 Heterogeneity of treatment effect across studies /appendixes/appendix-4-heterogeneity-of-treatment-effect-across-studies.html 70902 1142 0.619127395
PBAC Guidelines | Appendix 5 Translating comparative treatment effects of proposed surrogate measures to target clinical outcomes /appendixes/appendix-5.html 95649 4302 0.772198304
PBAC Guidelines | Appendix 6 Including nonhealth outcomes in a supplementary analysis /appendixes/appendix-6-including-nonhealth-outcomes-in-a-supplementary-analysis.html 46840 1529 0.606609729
/content/information/archived-versions/pbac-guidelines-1995.doc 209408 0 0.164377095
/content/information/archived-versions/pbac-guidelines-2002.pdf 299277 0 0.150842073
/content/information/archived-versions/pbac-guidelines-interim-version-to-industry-2000.doc 58368 0 0.235619268
/content/information/archived-versions/pbac-guidelines-v4-2006.doc 1679872 0 0.151756191
/content/information/archived-versions/pbac-guidelines-v4-2006.pdf 1010202 0 0.726658767
/content/information/archived-versions/pbac-guidelines-v4-3-2008.doc 1831936 0 0.536647115
/content/information/archived-versions/pbac-guidelines-v4-3-2008.pdf 1281581 0 0.14958041
/content/information/archived-versions/pbac-guidelines-v4-5.pdf 3926028 0 0.788284858
/content/information/files/pbac-guidelines-version-5.docx 6619438 85835 0.779068157
/content/information/files/pbac-guidelines-version-5.pdf 3752922 0 0.73927228
/content/information/templates/ABATACEPT-template-example.docx 30886 559 0.15902751
/content/information/templates/ADRENALINE-template-example.docx 20862 284 0.29076422
/content/information/templates/BOCEPREVIR-template-example.docx 22995 402 0.185650633
/content/information/templates/IVABRADINE-template-example.docx 21378 401 0.186128733
/content/information/templates/LACOSAMIDE-template-example.docx 21031 363 0.164881364
/content/information/templates/restriction-template.docx 17062 322 0.73157368
/content/information/templates/utilisation-and-cost-model.xlsx 648262 8430 0.19537734
PBAC Guidelines | Website Home Page /home.html 29190 575 0.597920411
PBAC Guidelines | Abbreviations and acronyms /information/abbreviations-acronyms.html 52237 819 0.656799259
PBAC Guidelines | About the Guidelines /information/about-the-guidelines.html 62963 2901 0.614347164
PBAC Guidelines | Checklists, Templates & Workbooks /information/checklists.html 41183 876 0.760142474
PBAC Guidelines | Contacts /information/contacts.html 41385 874 0.620821347
PBAC Guidelines | Document table /information/document-table.html 54042 1021 0.616320453
PBAC Guidelines | Flowcharts and figures /information/flowcharts-figures.html 43252 906 0.845762462
PBAC Guidelines | Foreword /information/foreword.html 42903 1141 0.174467918
PBAC Guidelines | Forms /information/forms.html 47729 1229 0.061074283
PBAC Guidelines | Printable version of PBAC guidelines /information/printable-version-of-guidelines.html 44992 977 0.646392979
PBAC Guidelines | Record of updates /information/record-of-updates.html 47951 902 0.648667678
PBAC Guidelines | References /information/references.html 58448 2458 0.17716217
PBAC Guidelines | Contents /information/table-of-contents.html 56540 1224 0.608348214
PBAC Guidelines | Tables /information/tables.html 51440 1198 0.616428486
PBAC Guidelines | Product type 1 – Fixed-dose combination products /product-type-1-fixed-dose-combination-products.html 40534 866 0.600479386
PBAC Guidelines | P1.1 Listing fixed-dose combination products /product-type-1/p1.1_listing_fixed-dose_combination_products.html 61432 2765 0.176597203
PBAC Guidelines | Product type 2 – Nutritional products /product-type-2-nutritional-products.html 39972 803 0.605190034
PBAC Guidelines | P2.1 Details of proposed product and its comparators (Section 1) /product-type-2/p2-1-details-of-proposed-product-and-its-comparators-section.html 55000 2203 0.195236189
PBAC Guidelines | P2.2 Clinical evaluation (Section 2) /product-type-2/p2-2-clinical-evaluation-section-2.html 40397 829 0.195248476
PBAC Guidelines | P3.1 Details of the proposed vaccine and its comparator (Section 1) /product-type-3/p3-1-details-of-the-proposed-vaccine-and-its-comparator-section-1.html 54687 2223 0.174654456
PBAC Guidelines | P3.2 Clinical evaluation (Section 2) /product-type-3/p3-2-clinical-evaluation-section-2.html 43230 1078 0.18359617
PBAC Guidelines | P3.3 Economic evaluation (Section 3) /product-type-3/p3-3-economic-evaluation-section-3.html 50649 1813 0.173632477
PBAC Guidelines | P3.4 Budgetary implications (Section 4) /product-type-3/p3-4-budgetary-implications-section-4.html 42802 1073 0.193395691
PBAC Guidelines | Product type 3 – Vaccine products /product-type-3-vaccine-products.html 39918 808 0.621103741
PBAC Guidelines | Product type 4 – Codependent technologies /product-type-4-codependent-technologies.html 48458 1638 0.608321463
PBAC Guidelines | P4.1 Overview of information requested in codependent submissions /product-type-4/p4-1-overview-of-information-requested-in-codependent-submissions.html 51551 1917 0.17676131
PBAC Guidelines | P4.2 Specific codependent technology information requests /product-type-4/p4-2-specific-codependent-technology-information-requests.html 40932 922 0.180588538
PBAC Guidelines | Section 1 - Context /product-type-4/section-1-context.html 69637 3776 0.175489117
PBAC Guidelines | Section 2 - Clinical evaluation /product-type-4/section-2-clinical-evaluation.html 80930 4805 0.192522537
PBAC Guidelines | Section 3 - Economic evaluation /product-type-4/section-3-economic-evaluation.html 63529 3020 0.202139264
PBAC Guidelines | Section 4 - Use of the medicine in practice /product-type-4/section-4-use-of-the-medicine-in-practice.html 45014 1329 0.218564657
PBAC Guidelines | 1.1 Clinical issue addressed by the submission /section-1/1-1-clinical-issue-addressed_by-the-submission.html 59043 2065 0.720414835
PBAC Guidelines | 1.2 Clinical management /section-1/1-2-clinical-management.html 47141 1503 0.188445449
PBAC Guidelines | 1.3 Regulatory process /section-1/1-3-regulatory-process.html 48968 1038 0.207824702
PBAC Guidelines | 1.4 Proposed PBS listing /section-1/1-4-proposed-pbs-listing.html 64641 2586 0.17780307
PBAC Guidelines | Section 1 Context /section-1-context.html 40618 832 0.610963528
PBAC Guidelines | 2.1 Literature search methods /section-2/2-1-literature-search-methods.html 45678 1331 0.191142301
PBAC Guidelines | 2.2 Identify relevant trials /section-2/2-2-identify-relevant-trials.html 46772 1456 0.188153859
PBAC Guidelines | 2.3 Trial design and execution /section-2/2-3-trial-design-and-execution.html 83142 2317 0.190364826
PBAC Guidelines | 2.4 Trial characteristics /section-2/2-4-trial-characteristics.html 79701 3544 0.188451808
PBAC Guidelines | 2.5 Trial results: whole trial population /section-2/2-5-trial-results-whole-trial-population.html 78396 2659 0.195158246
PBAC Guidelines | 2.6 Trial results: additional analyses /section-2/2-6-trial-results-additional-analyses.html 131415 5411 0.21620787
PBAC Guidelines | 2.7 Assessment of differences between the trial setting and the Australian setting after listing /section-2/2-7-assessment-of-differences.html 56154 1873 0.225333151
PBAC Guidelines | 2.8 Interpretation of the clinical evidence /section-2/2-8-interpretation-of-the-clinical-evidence.html 44297 1174 0.185708195
PBAC Guidelines | Section 2 Clinical evaluation /section2-clinical-evaluation.html 42129 1003 0.187447345
PBAC Guidelines | 3A.1 Overview and rationale of the economic evaluation /section-3a/3a-1-overview-and-rationale-of-economic-evaluation.html 61637 2404 0.187612701
PBAC Guidelines | 3A.2 Computational methods and structure of the economic analysis /section-3a/3a-2-computational-methods-and-structure-of-economic_analysis.html 56351 2440 0.192249141
PBAC Guidelines | 3A.3 Population and setting /section-3a/3a-3-population-and-setting.html 48289 1554 0.182344574
PBAC Guidelines | 3A.4 Model transition probabilities or variables, transformation and extrapolation /section-3a/3a-4-model-transition-probabilities-or-variables-transformation-extrapolation.html 55054 2316 0.1899734
PBAC Guidelines | 3A.5 Health outcomes /section-3a/3a-5-health-outcomes.html 64651 2654 0.198251502
PBAC Guidelines | 3A.6 Health care resource use and costs /section-3a/3a-6-health-care-resource-use-and-costs.html 60647 1902 0.192671381
PBAC Guidelines | 3A.7 Model validation /section-3a/3a-7-model-validation.html 42491 1055 0.190559271
PBAC Guidelines | 3A.8 Results of the base-case economic evaluation /section-3a/3a-8-results-of-the-base-case-economic-evaluation.html 111873 2221 0.187005351
PBAC Guidelines | 3A.9 Uncertainty analysis: model inputs and assumptions /section-3a/3a-9-uncertainty-analysis-model-inputs-and-assumptions.html 81890 2217 0.194605439
PBAC Guidelines | Section 3A Cost-effectiveness analysis /section-3a-cost-effectiveness-analysis.html 40515 852 0.614981957
PBAC Guidelines | 3B.1 Overview and rationale for the cost-minimisation approach /section-3b/3b-1-overview-and-rationale-for-the-cost-minimisation-approach.html 44861 883 0.24844851
PBAC Guidelines | 3B.2 Estimation of equi-effective doses /section-3b/3b-2-estimation-of-equi-effective-doses.html 45908 1397 0.189158193
PBAC Guidelines | 3B.3 Additional costs and/or cost offsets /section-3b/3b-3-additional-costs-and-or-cost-offsets.html 44301 1231 0.198896945
PBAC Guidelines | 3B.4 Results /section-3b/3b-4-results.html 41295 910 0.183102221
PBAC Guidelines | Section 3B Cost minimisation /section-3b-cost-minimisation.html 41462 915 0.614386985
PBAC Guidelines | Section 3 Economic evaluation /section-3-economic-evaluation.html 41885 960 0.674971698
PBAC Guidelines | 4.1 Justification of the selection of data sources /section-4/4-1-justification-of-the-selection-of-data-sources.html 50242 1394 0.189287995
PBAC Guidelines | 4.2 Estimation of use and financial impact of the proposed medicine /section-4/4-2-estimation-of-use-and-financial-impact-of-the-proposed-medicine.html 58887 2646 0.18907405
PBAC Guidelines | 4.3 Estimation of changes in use and financial impact of other medicines /section-4/4-3-estimation-of-changes-in-use-and-financial-impact-of-other-medicines.html 47635 1538 0.196207451
PBAC Guidelines | 4.4 Estimated financial impact for the PBS/RPBS or the NIP /section-4/4-4-estimated-financial-impact-for-the-pbs-rpbs-or-the-nip.html 41027 881 0.198308019
PBAC Guidelines | 4.5 Estimated financial implications for the health budget /section-4/4-5-estimated-financial-implications-for-the-health-budget.html 48266 1595 0.175457514
PBAC Guidelines | 4.6 Identification, estimation and reduction of uncertainty /section-4/4-6-identification-estimation-and-reduction-of-uncertainty.html 53858 2143 0.183134508
PBAC Guidelines | 4.7 Quality use of medicines /section-4/4-7-quality-use-of-medicines.html 44283 1177 0.187015134
PBAC Guidelines | Section 4 Use of the medicine in practice /section-4-use-of-the-medicine-in-practice.html 51296 1940 0.614728586
PBAC Guidelines | 5.1 Issues influencing decision making /section-5/5-1-issues-influencing-decision-making.html 39525 771 0.198172138
PBAC Guidelines | 5.2 Supplementary analyses /section-5/5-2-supplementary-analyses.html 39923 800 0.204121451
PBAC Guidelines | 5.3 Prudent-use principles for antimicrobial agents /section-5/5-3-prudent-use-principles-for-antimicrobial-agents.html 40026 826 0.181206656
PBAC Guidelines | 5.4 Basis for any claim for the ‘rule of rescue’ /section-5/5-4-basis-for-any-claim-for-the-rule-of-rescue.html 43372 1207 0.175082788
PBAC Guidelines | Section 5 Options to present additional relevant information /section-5-options-to-present-additional-relevant-information.html 41200 863 0.614339025
PBAC Guidelines | Submission executive summary /submission-executive-summary.html 52634 1151 0.608049655